Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Study tracks RAMP3's role in breast cancer immunity in mice

Cancer immunotherapy uses the body's defenses to attack cancer, but it does not help every patient. One reason may be the environment surrounding a tumor. Macrophages normally clear damaged cells, but some can suppress immune responses inside tumors, making it harder for cancer-fighting cells to work.

Study tracks RAMP3's role in breast cancer immunity in mice

A recent study led by researchers from Shinshu University in Japan has investigated the role of receptor activity-modifying protein 3 (RAMP3) in breast cancer immunity, specifically in mice. The research team, including doctoral student Yan Zhang, Dr. Megumu Tanaka, and Professor Takayuki Shindo, explored how RAMP3 influences the tumor environment and immune cell activity.

By comparing mice with and without RAMP3, the study found that those lacking the gene developed smaller primary tumors, less lung spread, and longer survival. Additionally, these mice had fewer immune-suppressing macrophages and more CD8⁺ T cells, which can attack cancer cells. The findings suggest that RAMP3 removal alters the tumor environment to favor immune activity.

The researchers also noted that macrophages in RAMP3-lacking mice were less likely to adopt an immune-suppressing state and exhibited reduced activity in the IL-4/STAT6 signaling pathway and lower levels of CCL8, a molecule associated with immune suppression. While the study's results are promising, further research is needed to confirm the findings and explore RAMP3 as a potential treatment target for breast cancer.

Brief written by urgent.news from Medical Xpress's own syndicated text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Tuesday 17 November →